Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Fournier selects 15-deoxyspergualin derivative for clinical evaluation

Oct. 29, 1999

Protein Design Labs and Roche expand Zenapax partnership

Oct. 27, 1999

Chinese researchers isolate new immunosuppressive fungal metabolite

Oct. 26, 1999

CDC advisory committee recommends Wyeth-Lederle's pneumococcal conjugate vaccine for routine use

Oct. 26, 1999

Another major milestone announced for Wyeth Lederle Vaccines' pneumococcal vaccine

Oct. 22, 1999

Biogen places anti-CD40 ligand MAb studies on hold

Oct. 22, 1999

Preclinical data for FTY-720 presented at recent Japanese meetings

Oct. 22, 1999

Wyeth is first to cross the finish line with meningococcal group C conjugate vaccine

Oct. 22, 1999

Phase II clinical trials initiated for humanized anti-CD3 antibody developed at PDL

Oct. 21, 1999

North American Vaccine awarded contract to supply NeisVac-C in U.K.

Oct. 20, 1999

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...